Literature DB >> 3728623

Neodymium-YAG laser iridectomies in glaucoma associated with closed or occludable angles.

L W Schwartz, M R Moster, G L Spaeth, R P Wilson, E Poryzees.   

Abstract

A review of our first 200 neodymium-YAG laser iridectomies performed over a two-year period in various forms of glaucoma showed patent iridectomies in 180 of 182 eyes (99% success) at the last examination (one to 26 months postoperatively). Both failures had preexisting chronic uveitis. Eighteen eyes were lost to follow-up. Complications included intraocular pressure increased more than 10 mm Hg in 54 eyes (30%), hemorrhage in 36 eyes (20%), iritis in 21 eyes (11.5%), posterior synechiae in 13 eyes (7%), corneal changes in seven eyes (4%), and pupillary distortion in six eyes (3%). With experience, fewer applications are required to penetrate the iris, and retreatment to obtain patency is less likely to be needed.

Entities:  

Mesh:

Year:  1986        PMID: 3728623     DOI: 10.1016/0002-9394(86)90207-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  18 in total

1.  Nd: Yag laser iridotomy in Shaffer-Etienne grade 1 and 2: angle widening in our case studies.

Authors:  Sandra Cinzia Carlesimo; Luigi Di Santo; Pietro Bruni; Aloisa Librando; Antonietta Pompea Falace; Andrea Barbato
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

Review 2.  Laser light: its nature and its action on the eye.

Authors:  F M Bessette; L C Nguyen
Journal:  CMAJ       Date:  1989-12-01       Impact factor: 8.262

3.  Laser iridotomy in dark irides.

Authors:  Don Julian de Silva; Gus Gazzard; Paul Foster
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

4.  Initial clinical experience with the picosecond Nd:YLF laser for intraocular therapeutic applications.

Authors:  G Geerling; J Roider; U Schmidt-Erfurt; K Nahen; H Laqua; A Vogel
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

5.  The role of apraclonidine hydrochloride in laser therapy for glaucoma.

Authors:  A L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  1989

6.  Neodymium: YAG laser iridotomies--short-term comparison with capsulotomies and long-term follow-up.

Authors:  C R Canning; M R Capon; E S Sherrard; M G Kerr Muir; R Pearson; R J Cooling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

7.  Nd:YAG laser photodisruption: an experimental investigation on shielding and multiple plasma formation.

Authors:  M R Capon; F Docchio; J Mellerio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

8.  The prevention of an acute rise in intraocular pressure following Q-switched Nd:YAG laser iridotomy with clonidine.

Authors:  Y Kitazawa; K Sugiyama; T Taniguchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

9.  YAG laser iridotomy treatment for primary angle closure in east Asian eyes.

Authors:  W P Nolan; P J Foster; J G Devereux; D Uranchimeg; G J Johnson; J Baasanhu
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

10.  Efficacy of Nd-YAG laser iridotomies in acute angle closure glaucoma.

Authors:  R H Gray; J H Nairne; W H Ayliffe
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.